Scientists have identified an “epilepsy belt” that stretches across the U.S. south. Researchers looked at data from nearly 5 ...
The risk for a diagnosis of epilepsy is more than two times greater for those with depression, although incidence is low, ...
Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of ...
A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy (DRE) who were not referred for surgical evaluation and flagged those overdue ...
This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.
Individuals with epilepsy and depression had a higher psychiatric comorbidity burden linked to shorter duration of initial therapy and a higher risk of treatment failure, data show.“Limited research ...
Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...
PsyPost on MSN
Epilepsy drug topiramate shows mixed results for treating combined alcohol and tobacco use
An 18-week experimental study examining the effects of topiramate on tobacco smoking and alcohol use found no differences ...
Several risk factors may impact the long-term outlook for individuals with epilepsy, such as being over age 60 years, having a brain infection, having a family history of seizures, and having a health ...
A combination of missed prevention opportunities and health inequalities can result in the early deaths of people living with ...
The Morning Journal on MSN
Lorain educator publishes memoir on living with epilepsy
Lorain educator and author Jennifer Richardson is hoping her new book will help broaden community understanding of epilepsy, a chronic neurological disorder, and the realities faced by those who ...
Stocktwits on MSN
Biohaven stock slumps after hours as failed depression study adds to a brutal 2025 — retail eyes epilepsy and obesity catalysts
The company also announced that it does not plan on additional psychiatric clinical trials and intends to prioritize its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results